| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/08/2010 | CN101033230B Cmptothecine derivative and application thereof |
| 12/08/2010 | CN101032525B Extracting active principles having extracorporeal anti-tumor function from housefly larva |
| 12/08/2010 | CN101032336B Pearl flavone nutrient health care food and preparation process thereof |
| 12/08/2010 | CN101031572B (R/S) rifamycin derivatives, their preparation and pharmaceutical compositions |
| 12/08/2010 | CN101028525B Use of tumor caryon single-antibody in physical therapeutic tumor as synergist |
| 12/08/2010 | CN101024022B External dressing medicine bag for treating stomachache |
| 12/08/2010 | CN101022779B Antifungal drug delivery |
| 12/08/2010 | CN101018537B Wrinkle reduction agent, lipolysis accelerator, composition for external use on skin, and food or beverage composition |
| 12/08/2010 | CN101015557B Combination of an inhibitor of the If current of the sinus node and an inhibitor of the angiotensin converting enzyme, and pharmaceutical ingredients containing said association |
| 12/08/2010 | CN101011477B Shangqing pills formula and its production process |
| 12/08/2010 | CN101007130B An antibiotic and anti-inflammation traditional Chinese medicine composition and its preparation method |
| 12/08/2010 | CN100999521B Crystal anti-choline medicine thiatropic bromoammonium |
| 12/08/2010 | CN100999470B Salvia minium phenolic acid A and process of preparing preparation and use |
| 12/08/2010 | CN100998575B Finger nail coating agent of antifungal agent and its preparing method |
| 12/07/2010 | USRE41990 epothilone derivatives used for the treatment of cancer and cancers which have developed a multidrug-resistant phenotype; anticarcinogenic agents |
| 12/07/2010 | US7847835 Still camera with audio decoding and coding, a printable audio format, and method |
| 12/07/2010 | US7847156 Plants having improved growth characteristics and methods for making the same |
| 12/07/2010 | US7847132 administering 2,3,5-trimethyl hydroquinone-1-hexylether or 2,3,5-trimethyl hydroquinone-1-hexylether 4-acetate, to inhibits the expression of naofen, an intracellular protein newly found as an anti-verotoxin 2 (VT2) antibody reactive substance |
| 12/07/2010 | US7847123 e.g. Octyl-N-(2-ethylhexyl)Lactamide; controlling microorganisms in a cosmetic preparation; grampositive bacteria: Corynebacterium xerosis, Propionibacterium acnes, Malassezia furfur; aerosols, pump sprays, deodorant sticks, dry deodorant sprays, wipes, acne/dandruff production |
| 12/07/2010 | US7847122 histone deacetylase (HDAC) inhibitor useful in selectively inducing terminal differentiation, cell growth arrest and/or apoptosis of neoplastic cells; have a high bioavailability and gives high blood levels of the active compounds over a long time |
| 12/07/2010 | US7847120 Compositions of allosteric hemoglobin modifiers and methods of making the same |
| 12/07/2010 | US7847119 Drug conjugates |
| 12/07/2010 | US7847112 Polymorphs of atovaquone and process of preparation thereof |
| 12/07/2010 | US7847109 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 12/07/2010 | US7847101 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors |
| 12/07/2010 | US7847100 enzyme ihibitors such as 3-{5-[(1R)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide, used for treating neurodegenerative diseases |
| 12/07/2010 | US7847096 pyrimidine- or pyridinecarboxylic acid derivatives which are substituted in the 2- or 4-position by an optionally substituted 4-(3-oxomorpholin-4-yl)aniline radical, such as 6-methyl-2-[4-(3-oxomorpholin-4-yl)phenylamino]nicotinic acid, suitable for the treatment of viral diseases, such as hepatitis C |
| 12/07/2010 | US7847095 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1.,2,4-triazol-3-one |
| 12/07/2010 | US7847091 target heat shock protein (hsp) 27 in vivo; antisense oligonucleotide or RNAi nucleotide inhibitor with sequence specificity for hsp27 mRNA; injectable dosage unit form |
| 12/07/2010 | US7847089 RNA interference induction element and use thereof |
| 12/07/2010 | US7847014 Suitable for producing active substance-containing pressure sensitive adhesive layers or adhesive matrices for active substance release in the field of human or veterinary medicine, e.g. as components of transdermal therapeutic systems |
| 12/07/2010 | US7846975 High permeability through plasma membrane, nuclear membrane and blood-brain barrier; for delivering doxorubicin and paclitaxel to target cells; gene therapy |
| 12/07/2010 | US7846974 Method of lowering blood glucose and method of treating diabetes and obesity |
| 12/07/2010 | US7846973 Chemical process and new crystalline form |
| 12/07/2010 | US7846972 Multimeric oleamide derivative having connexin-26 inhibiting potency and use thereof in cancer therapy, etc |
| 12/07/2010 | US7846971 N-halogenated amino acids, N,N-dihalogenated amino acids and derivatives; compositions and methods of using them |
| 12/07/2010 | US7846969 Ceramide emulsions |
| 12/07/2010 | US7846967 isolated from Cnidium officinale and Ligusticum chuanxiong; inhibiting melanocyte-stimulating hormone |
| 12/07/2010 | US7846966 treating an estrogen-receptor related condition such as benign prostate hypertrophy or a menopausal complaints, comprising administering 4-benzyl-2-phenylchroman's such as 4-benzyl-3-methyl-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-6-ol, having surprisingly high estrogen receptor affinity |
| 12/07/2010 | US7846965 Compound |
| 12/07/2010 | US7846964 (1aS,5aR)-1,1,2-Trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pentalene-4-carboxylic acid; immunosuppressive agent; graft-versus-host disease, rheumatoid arthritis, multiple sclerosis, psoriasis, psoriatic arthritis, Crohn's disease, Hashimoto's thyroiditis and atopic dermatitis; translant rejection |
| 12/07/2010 | US7846963 such as 3-[1-(2,4-Dimethoxybenzyl)-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-N-hydroxypropionamide, used for preventing and treating the inflammatory diseases, for example rheumatoid arthritis, gout, osteoarthritis, lupus, arthritis, Crohn's disease, diabetes, bursitis, burns and scaring |
| 12/07/2010 | US7846962 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives, used for the treatment of cellular proliferative disorders, non-proliferative, degenerative disorders, viral infections, and/or disorders associated with viral infections |
| 12/07/2010 | US7846961 angiotensin converting enzyme inhibitors, used for the treatment of congestive heart failure aand as hypotensive agents; dissolving perindopril and L-arginine in water, adding apolar and polar solvents, then filtering, washing and drying the crystals obtained |
| 12/07/2010 | US7846960 FXR agonists |
| 12/07/2010 | US7846959 Raf modulators and methods of use |
| 12/07/2010 | US7846957 Aromatase inhibition to enhance assisted reproduction |
| 12/07/2010 | US7846956 Malononitrile compound as pesticides |
| 12/07/2010 | US7846955 Salt |
| 12/07/2010 | US7846953 such as 4-[4-(2,4-Dioxo-thiazolidin-5-ylidenemethyl)-2-methoxy-phenoxy]-3-trifluoromethyl-benzonitrile, used for the treatment of ankylosing spondylitis, atherosclerosis, arthritis, bone disorders, breast cancer, autoimmune dsieases, cardiovascular, metabolic and respiratory system disorders |
| 12/07/2010 | US7846952 epothilone derivatives in combination with carriers or diluents, used for plant protection in agriculture, forestry or horticulture; plant safening agents |
| 12/07/2010 | US7846951 treating cystic fibrosis, emphysema, or chronic obstructive pulmonary disease, comprising administering to a patient azole-4-carboxamide derivatives such as N,N-dibenzyl-2-[(2,6-dichlorophenyl)methyl]-1,3-thiazole-4-carboxamide |
| 12/07/2010 | US7846950 Histamine H3 receptor inhibitors, preparation and therapeutic uses |
| 12/07/2010 | US7846949 liver X receptors (LXR) modulators such as Tert-butyl 2-(2,4,6-trifluoro-N-(3-hydroxyphenyl benzamido)acetate, useful in the treatment of LXR-associated diseases such as cardiovascular disorders, inflammation and disorders of glucose metabolism such as insulin resistance and obesity |
| 12/07/2010 | US7846947 For treatment of wounds, atopic dermatitides, infected eczemas, dermatomycoses, vaginal infections, acne, herpes and/or for controlling multidrug-resistant pathogens |
| 12/07/2010 | US7846946 Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists |
| 12/07/2010 | US7846945 2-[4-Chloro-3-(4-hydroxy-benzyl)-phenyl]-6-methoxy-tetrahydro-pyran-3,4,5-triol; 2-[4-Chloro-3-(4-ethoxy-benzyl)-phenyl]-3,4,5-trihydroxy-piperidine-1-carboxylic acid methyl ester; (2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-methoxytetrahydro-2H-thiopyran-3,4,5-triol; antidibetic, antiobesity agents |
| 12/07/2010 | US7846944 P38 map kinase inhibitors such as N-cyclopropyl-3-(7-ethyl-1-(2-fluorophenyl)-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-5-yl)-5-fluoro-4-methylbenzamide, used for the treatment of rheumatoid arthritis, psoriasis, chronic obstructive pulmonary disease, pain and other inflammatory disorders |
| 12/07/2010 | US7846943 Hormone sensitive diseases; atherosclerosis; cardiovascular disorders; congestive heart failure; antidiabetic agents; metaboolism disorders; reducing triglycweride concentration |
| 12/07/2010 | US7846942 Such as 3-isobutyryl-2-isopropyl pyrazolo[1,5-a]pyridine; for treatment of Parkinson's disease, Huntington's disease, Alzheimer's disease, and schizophrenia |
| 12/07/2010 | US7846941 Compounds modulating c-kit and c-fms activity and uses therefor |
| 12/07/2010 | US7846940 Solution formulations of sirolimus and its analogs for CAD treatment |
| 12/07/2010 | US7846939 salts of N-acridonacetic acid such as N-(1-deoxy-D-glucitol-1-yl)-N-ethyl ammonium 9-oxoacridine-10-ylacetate, having immunomodulating, antiparasitic, antisclerotic, antiviral, antibacterial, antifungal, antiphlogistic, antitumor, radioprotective and stressprotective activities |
| 12/07/2010 | US7846938 Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moiety |
| 12/07/2010 | US7846937 such as 1-amino-cyclopropanecarboxylic acid 2-(2-amino-6-oxo-1,6-dihydro-purin-9-ylmethoxy)-ethyl ester, having unexpected stability to acid and base conditions, used for treating hepes infections; acylating acyclovir with 1-tert-butoxycarbonylamino-cyclopropanecarboxylic acid, the deprotecting the amine |
| 12/07/2010 | US7846936 Antagonists of receptors of enothelial growth factor, platelet-derived growth factor, fibroblast growth factor, epidermal growth factors, HER2, IGF1R, HGFR or c-Kit, which is further an antagonist of a src tyrosine kinase family member, and chemotherapeutic agent; co-treatment with radiation therapy |
| 12/07/2010 | US7846935 Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors |
| 12/07/2010 | US7846934 N-((S)-1-cyclopentyl-2-oxo-2-((3aS,6aR)-3-oxodihydro-2H-furo[3,2-b]pyrrol-4(5H,6H,6aH)-yl)ethyl)-4-(4-methylpiperazin-1-yl)benzamide; osteoporosis, Paget's disease, Chagas's, malaria, gingival diseases, hypercalcemia, metabolic bone disease, bone cancer and associated pain |
| 12/07/2010 | US7846933 such as 1-(4-Fluorophenyl)-5-(pyridin-4-yl)-4-imidazolin-2-one, having excellent p38 MAP kinase inhibitory action, useful for the treatment of osteoarthritis, arthritis, ulcerative colitis, Crohn's disease, psoriasis, dermatitis, asthma, bronchitis, pneumonia, rhinitis, conjunctivitis or keratitis |
| 12/07/2010 | US7846932 Methods for the use of pyrimidine derivatives which are antagonists of vitronectin receptor |
| 12/07/2010 | US7846931 Pyrrolotriazine compounds as kinase inhibitors |
| 12/07/2010 | US7846930 2-Methyl-4-(4-methylsulfanyl-phenyl)-7-(3-piperidin-1-ylmethyl-phenoxy)-1,2,3,4-tetrahydro-isoquinoline, used for the treatment of cognitive disorders, sleep disorders and psychiatric disorders |
| 12/07/2010 | US7846929 Using 1-(4-((2-(aminopyrimidin-5-yl)-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-(methylsulfonyl)ethanone; lipid kinase inhibitor; anticancer agents ; antiinflammatory agents; antidiabetic agents |
| 12/07/2010 | US7846928 Interfere with Tie2 signalling; Tie (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain) receptor tyrosine kinase; antitumor, antimetastasis agents; for example, 1-[4-(6-tert-Butyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-phenyl]-3-(3-ethyl-phenyl)-urea |
| 12/07/2010 | US7846927 N,N′-diphenylurea derivatives suitable as kinase inhibitors |
| 12/07/2010 | US7846926 podophyllotoxin derivatives such as (2-{3-[4-(3-aminopropylamino)-butylamino]-propylamino}-N-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5,6,8,8a,9-hexahydrofuro[3',4':6,7]naptho[2,3-d][1,3]dioxol-5-yl]-acetamide, used as anticarcinogenic agents |
| 12/07/2010 | US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries |
| 12/07/2010 | US7846924 Cyanopyrroles |
| 12/07/2010 | US7846923 such as N-ethyl-3-(9-ethyl-8-oxo-8,9-dihydro-3H-3,4,9-triaza-cyclopenta[a]naphthalen-7-yl)-5-methoxy-benzamide, used to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity |
| 12/07/2010 | US7846922 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators |
| 12/07/2010 | US7846921 Method of relieving symptoms of gastroesophageal reflux disease |
| 12/07/2010 | US7846920 Bactericides; bacteriostats; therapy for bacteria infections |
| 12/07/2010 | US7846919 Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions |
| 12/07/2010 | US7846918 Exemestane compounds, compositions and related methods of use |
| 12/07/2010 | US7846917 18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same |
| 12/07/2010 | US7846916 Steroid on carrier containing pressure sensitive adhesive |
| 12/07/2010 | US7846915 polyphenol compounds, such as 4,4'-dihydroxy-stilbene, useful for regulating the expression of apolipoprotein, used in the treatment and prevention of cardiovascular, cholesterol or lipid related disorders, such as atherosclerosis |
| 12/07/2010 | US7846914 Composition for the treatment and prevention of endothelial dysfunction |
| 12/07/2010 | US7846913 Include insomnia, erectile dysfunction, female sexual dysfunction, neuropathic pain, attention deficit disorder, and depression; NMDA receptor agonists as a learning-enhancing secondary drug that improves the efficacy of a primary drug by locking in the psychological benefits derived from primary drugs |
| 12/07/2010 | US7846912 Deuterium-enriched nelarabine |
| 12/07/2010 | US7846911 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia |
| 12/07/2010 | US7846908 RNAi modulation of TGF-beta and therapeutic uses thereof |
| 12/07/2010 | US7846906 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 12/07/2010 | US7846904 Compositions and methods for increasing telomerase activity |
| 12/07/2010 | US7846903 cubic liquid crystal formulation containing an amphiphilic compound such as 1-O-(5,9,13-trimethyltetradecyl)erythritol and a drug ( excluding a lysosomal enzyme) or cosmetic embedded in the cubic liquid crystal; time release agent |
| 12/07/2010 | US7846725 Mammalian cell demonstrating GDP-mannose 4,6-dehydratase (GMD) suppression and which expresses immunoglobulin associated with antibody-dependent cellular cytotoxicity; targeted treatment of tumors |
| 12/07/2010 | US7846723 Methods of identifying anti-cancer agents and uses thereof |
| 12/07/2010 | US7846679 Methods for detecting the presence of mutant mammalian presenilin protein |
| 12/07/2010 | US7846651 Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same |
| 12/07/2010 | US7846478 Bioadhesive composition |